Loading clinical trials...
Loading clinical trials...
The purpose of this clinical trial is learn whether a behavioral (non-medication) treatment can reduce nightmares in adults with Rapid Eye Movement (REM) Sleep Behavior Disorder (RBD). People with RBD will be enrolled in the study along with their family members (a partner or other family member residing in the same home). All participants will receive the treatment via videoconference and will complete 2 assessments. Participants with RBD will attend 7 sessions, and their family members will attend 2 of those sessions with them.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
University of Utah
Salt Lake City, Utah, United States
Start Date
July 15, 2024
Primary Completion Date
December 1, 2026
Completion Date
December 1, 2026
Last Updated
March 12, 2026
20
ESTIMATED participants
Cognitive Behavioral Therapy for Nightmares
BEHAVIORAL
Lead Sponsor
University of Utah
NCT07069517
NCT07121270
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions